Jasminelle (Drospirenone, Ethinylestradiol)

• Jasminelle, a combined oral contraceptive, is indicated for hormonal contraception to prevent pregnancy.
• Prevention of pregnancy: provides reliable contraceptive protection when taken as prescribed.
• Regulation of menstrual cycle: helps establish more predictable bleeding patterns.
• Reduction of ovarian cysts: decreases the incidence of functional ovarian cyst formation.

• Drospirenone acts as a progestogenic agent with anti‑mineralocorticoid and anti‑androgenic activity, while ethinylestradiol provides estrogenic support. Together they suppress the hypothalamic‑pituitary‑ovarian axis, inhibiting luteinising hormone (LH) and follicle‑stimulating hormone (FSH) release, thereby preventing ovulation. They also thicken cervical mucus and modify the endometrial lining to reduce the chance of implantation.

Jasminelle may cause a range of adverse reactions. Users should be aware of both common and less frequent but serious events.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Breast tenderness: discomfort or swelling of the breasts.
• Headache: occasional mild to moderate headaches.
• Spotting: irregular light bleeding between periods.
• Mood changes: fluctuations in emotional state.
• Weight gain: modest increase in body weight.

Serious or Rare Side Effects

• Venous thromboembolism: blood clots in deep veins or lungs.
• Arterial thrombosis: clot formation in arteries leading to stroke or heart attack.
• Hypertension: elevated blood pressure.
• Liver disorders: jaundice or hepatic dysfunction.
• Gallbladder disease: formation of gallstones.
• Severe allergic reaction: rash, swelling, or anaphylaxis.

• Before prescribing Jasminelle, clinicians should evaluate patient history and risk factors.
• Contraindications: avoid use in women with a history of thromboembolic disorders.
• Smoking: do not use in patients over 35 who smoke cigarettes.
• Medication review: assess concomitant use of enzyme‑inducing drugs that may reduce efficacy.
• Pregnancy: discontinue immediately if pregnancy is confirmed.
• Breastfeeding: consult a healthcare provider before use.
• Store at ambient temperature below 25°C: keep in the original pack, protect from moisture and light.

Jasminelle can interact with several medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

• Strong CYP3A4 inducers (e.g., rifampin, carbamazepine) may markedly reduce contraceptive efficacy.
• Anticoagulants (e.g., warfarin) may have altered anticoagulant effect.
• Certain antiepileptics (e.g., phenobarbital) can decrease hormone levels.

Moderate Interactions (Monitor Closely)

• Antifungals such as fluconazole may increase hormone concentrations.
• Some antiretrovirals (e.g., protease inhibitors) can affect metabolism.
• Herbal supplements like St. John’s wort may reduce contraceptive effectiveness.